CliffBio
biologic

Jivi

Antihemophilic factor (recombinant), PEGylated-aucl

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameJivi
Active ingredientAntihemophilic factor (recombinant), PEGylated-aucl
Strength4000IU
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
Marketing statusRx

More from Bayer Healthcare

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.